East Windsor, New Jersey, AuroMedics Pharma LLC is voluntarily recalling two lots of Piperacillin and Tazobactam for injection, USP 3.375 g (Piperacillin Sodium equivalent to 3 g of Piperacillin USP and Tazobactam Sodium equivalent to 0.375 g of Tazobactam USP. Each vial contains 7.05 mEq (162 mg) of Sodium) in a Single-Dose vial, to the hospital level. One vial from lot# PP0317012-A was found to contain particulate matter, identified as glass within the vial and another vial from lot# PP0317059-A was found to contain silicone material. This problem was discovered as a result of two product complaints in which the contents of one vial from batch PP0317012-A was found to contain a glass particle and the contents of one vial from batch PP0317059A was found to contain a silicone particle.
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2LSOlDd
via IFTTT
Tuesday, July 31, 2018
ADM Animal Nutrition Recalls Mintrate® 36-15 Breed Right Cattle Tub - A specific lot of product may contain elevated levels of non-protein nitrogen, could harm cattle - FDA Safety Alerts & Drug Recalls
ADM Animal Nutrition, a division of Archer Daniels Midland Company (NYSE: ADM), is recalling 200-pound tubs of Mintrate® 36-15 Breed Right Tub cattle feed, product number 54549AAA6H, because the product may contain elevated levels of non-protein nitrogen, which could be harmful to cattle. Excessive levels of non-protein nitrogen can be toxic to cattle and can cause muscle tremors (especially of face and ears), abdominal pain, bloat, frothy salivation, excessive urination, teeth grinding, incoordination, weakness, shortness of breath and possible death.
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2Oza01w
via IFTTT
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2Oza01w
via IFTTT
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance antimicrobial stewardship in veterinary settings - FDA Press Releases
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance antimicrobial stewardship in veterinary settings
from Food and Drug Administration--Press Releases https://ift.tt/2M6gaVp
via IFTTT
from Food and Drug Administration--Press Releases https://ift.tt/2M6gaVp
via IFTTT
Monday, July 30, 2018
FDA approves first treatment for rare adrenal tumors - FDA Press Releases
FDA approves first treatment for rare adrenal tumors
from Food and Drug Administration--Press Releases https://ift.tt/2mWc87i
via IFTTT
from Food and Drug Administration--Press Releases https://ift.tt/2mWc87i
via IFTTT
Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to safeguard women’s health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for “vaginal rejuvenation” - FDA Press Releases
FDA warns doctors and patients about deceptive claims on laser medical devices used to treat menopausal symptoms for “vaginal rejuvenation”
from Food and Drug Administration--Press Releases https://ift.tt/2mUIhMe
via IFTTT
from Food and Drug Administration--Press Releases https://ift.tt/2mUIhMe
via IFTTT
Saturday, July 28, 2018
Lipari Foods Issues Voluntary Recall of Premo Brand & Fresh Grab Turkey & Swiss Submarine Sandwiches Due to Potential Contamination of Listeria Monocytogenes - FDA Safety Alerts & Drug Recalls
Lipari Foods, LLC has issued a voluntary recall of Premo Brand and Fresh Grab turkey and Swiss submarine sandwiches produced and packaged by sister company JLM due to potential contamination of Listeria monocytogenes. Listeria monocytogenes is an organism, which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2mQALCj
via IFTTT
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2mQALCj
via IFTTT
Ranier’s Rx Laboratory Issues Voluntary Recall of All Sterile Compounded Products Within Expiry Due to Lack of Sterility Concerns - FDA Safety Alerts & Drug Recalls
Ranier’s Rx Laboratory is voluntarily recalling all sterile compounded drug products within expiry to the hospital or consumer level. These drug products are being voluntarily recalled due to concerns that practices at the pharmacy have the potential to pose a risk of contamination to products that are intended to be sterile. These concerns arose following a routine inspection of the pharmacy by FDA.
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2vaBvWD
via IFTTT
from Food and Drug Administration--Recalls/Safety Alerts https://ift.tt/2vaBvWD
via IFTTT
Subscribe to:
Posts (Atom)